IPAX-BRIGHT
LIVE

Serial Number

79426083

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

Apr 29, 2025

Add to watchlist:

No watchlists yet
View on USPTO

IPAX-BRIGHT Trademark

Serial Number: 79426083

IPAX-BRIGHT is a trademark filed by Telix Pharmaceuticals Limited on April 29, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

April 29, 2025

Registration Date

Not Registered

Published for Opposition

September 15, 2026

Goods & Services

Scientific research in the nature of conducting clinical trials for others in the field of cancer; clinical research in the field of cancer; testing of pharmaceuticals; laboratory testing of pharmaceuticals; medical research; pharmaceutical research consultancy; research and development in the field of pharmaceuticals

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 15, 2026 NPUB
PUBLISHED FOR OPPOSITION
Sep 15, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 9, 2026 NONP
NEW REPRESENTATIVE AT IB RECEIVED
Sep 3, 2026 NREP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 20, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 19, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 19, 2026 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jul 30, 2026 NREP
REFUSAL PROCESSED BY IB
Mar 12, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 25, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 25, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 30, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 29, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 29, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 28, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 28, 2026 NWOS
NEW REPRESENTATIVE AT IB RECEIVED
Jan 22, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 1, 2026 NREP
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 2, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 19, 2025 REPR